Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Interim Management Statement

21 Oct 2008 14:11

RNS Number : 3513G
Flying Brands Limited
21 October 2008
 



21 October 2008

Flying Brands Limited ('Flying Brands' or the 'Group')

Interim Management Statement for the three months to 26 September 2008

Flying Brands, the Jersey-based home shopping group, is today issuing an Interim Management Statement for the three months to 26 September 2008.

In the Trading Update released in September 2008, the Group explained that a series of recent adverse events had had a material impact on year-to-date trading and that management had responded with a number of actions to mitigate this shortfall in performance for the full year. These actions are progressing well and October trading is on forecast

Sales for the three months for the whole Group were £7.5(2007:£9.3m) and consistent with our expectations at the time of our recent Trading Update. Excluding the Greetings Direct business that is being closed down, sales for the three months were £5.6m being £0.9m down on those for the comparable period in 2007, around £0.3m of which is explained by timing.

The Garden Division's sales were down by £0.6m. £0.2m due to timing and the remainder due predominantly to the poor weather in August. 

The Entertainment Division's sales declined by £0.2m as a result of planned reduction in loss-making recruitment activity for Listen2 and a timing issue for Benham due to a delay by the Royal Mail in issuing their Olympics first day stamp covers.

Flying Flowers' sales were lower by £0.1m.

In terms of the financial position, net debt within the Group at 26 September was £4.8m. The Group continues to pay down this debt on schedule and to enjoy good relationship with its bank.

Tricia Killen, Chief Executivecommented:

"The mitigating actions, outlined in the recent Trading Update are progressing well and we are seeing improved response rates from our revamped promotional mailings.

From the beginning of this month, we have increased the selling price of selective Garden Bird Supplies products to offset rising ingredient costs and, in the first two weeks, our sales have been significantly higher than for the same period last year. We are confident that our projected gains from these price increases will be achieved.

This week, we are also implementing selective price increases across the Flying Flowers business to compensate for rising product costs. Our pricing remains very competitive versus others in the marketplace.

New Christmas catalogue campaigns have been developed for the significant active database of non Flying Flowers customers, who would not normally receive Christmas offers from Flying Brands and the first of these catalogues will be mailed this week."

For further information, please contact:

Flying Brands Limited 01245 228300

Patricia Killen, Chief Executive

Graham Norton, Finance Director

Smithfield Consultants 020 7360 4900

John Kiely

Notes to editors

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand home shopping group. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions:

* Gifts (Flying Flowers, the UK's largest flowers by post brand, despatching nearly one million bouquets a year; Greetings Direct, the UK's only continuity greeting cards business)

* Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Sarah Raven's Kitchen and Garden for hard to find plants and household accessories)

* Entertainment (Listen2, the leading mail order audio books, DVD and video publisher and distributor; Benham, the first day cover stamps and coins collectables specialist)

More information can be found at: www.flyingbrands.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSXFLFLVBBBFBQ
Date   Source Headline
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.